ArticleOncoTargets and therapy2013

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.

Arlhee Diaz-Miqueli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.